MIRAMAR, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (Nasdaq: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing ...
Hosted on MSN1mon
FDA approves HCW Biologics trial for alopecia treatmentDr. Hing C. Wong, Founder and CEO of HCW Biologics, expressed optimism about the trial, stating, "The FDA's clearance to initiate our first-in-human clinical trial for HCW9302 brings us one step ...
HCW Biologics received an extension from Nasdaq to regain compliance with listing rules by April 25 and June 15, 2025. HCW Biologics Inc., a clinical-stage biopharmaceutical company focused on ...
HCW Biologics Inc. is a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation ...
MIRAMAR, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering ...
HCW Biologics Inc. (“HCWB” or “HCW Biologics”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to ...
HCW Biologics (HCWB) reported that the Nasdaq Hearings Panel granted the company an extension in which to regain compliance with all continued ...
HCW Biologics, Inc MIRAMAR, Fla., March 06, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (Nasdaq: HCWB), a clinical-stage biopharmaceutical company ...
This study will evaluate HCW9302 in patients with moderate to severe alopecia areataMIRAMAR, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCWB” or the “Company”) (NASDAQ: HCWB), a U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback